1959
DOI: 10.1007/bf01491364
|View full text |Cite
|
Sign up to set email alerts
|

Die Aminos�ureausscheidung mit der Galle nach Bromsulphophthalein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

1961
1961
1976
1976

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 4 publications
0
1
0
1
Order By: Relevance
“…In the past, chlorpromazine hydrochloride-associated cholestasis has been attributed to hepatic hypersensitivity reactions (Gutman, 1957; Zelman, 1959;Popper & Schaffner, 1959;Zimmerman, 1963), inhibition of bilirubin secretion (Hargreaves, 1965), alteration of bile viscosity (Sharma & Prasad, 1967), precipitation of biliaryproteins (Clarke & Denborough, 1971) and spasm of the sphincter of Oddi (Moyer et al, 1954;Menguy et al, 1955), all without convincing pathophysiological proof. Although there is some direct experimental evidence that inhibition of bile flow both in dogs (Stefko & Zbinden, 1963;Sharma & Prasad, 1967) and in perfused rat liver preparations (Clodi & Schnack, 1960;Kendler et al, 1971) occurs with chlorpromazine hydrochloride and is related to dose, no physicochemical studies have been carried out on the interactions of the drug with bile salts, the major organic anions in mammalian bile, and the substances responsible for much of bile-water flow (Wheeler, 1969;Erlinger, 1972). At physiological pH one would expect that bile salts (Plate 1), which are anionic detergent-like molecules (Carey & Small, 1972), and chlorpromazine hydrochloride (Plate 1), which is acationicdetergent (Scholtan, 1955; Attwood et al, 1974), would be incompatible in solution owing to coulombic interactions between their ionic groups.…”
mentioning
confidence: 99%
“…In the past, chlorpromazine hydrochloride-associated cholestasis has been attributed to hepatic hypersensitivity reactions (Gutman, 1957; Zelman, 1959;Popper & Schaffner, 1959;Zimmerman, 1963), inhibition of bilirubin secretion (Hargreaves, 1965), alteration of bile viscosity (Sharma & Prasad, 1967), precipitation of biliaryproteins (Clarke & Denborough, 1971) and spasm of the sphincter of Oddi (Moyer et al, 1954;Menguy et al, 1955), all without convincing pathophysiological proof. Although there is some direct experimental evidence that inhibition of bile flow both in dogs (Stefko & Zbinden, 1963;Sharma & Prasad, 1967) and in perfused rat liver preparations (Clodi & Schnack, 1960;Kendler et al, 1971) occurs with chlorpromazine hydrochloride and is related to dose, no physicochemical studies have been carried out on the interactions of the drug with bile salts, the major organic anions in mammalian bile, and the substances responsible for much of bile-water flow (Wheeler, 1969;Erlinger, 1972). At physiological pH one would expect that bile salts (Plate 1), which are anionic detergent-like molecules (Carey & Small, 1972), and chlorpromazine hydrochloride (Plate 1), which is acationicdetergent (Scholtan, 1955; Attwood et al, 1974), would be incompatible in solution owing to coulombic interactions between their ionic groups.…”
mentioning
confidence: 99%
“…Der eigentliche Mechanismus, welcher der Leber ermöglicht, BSP in der Galle auf mehr als das lOOfache der Plasm akonzentration anzureichern, ist weitgehend unbekannt. Viel leicht gibt die kürzlich beschriebene Aminosäureausscheidung, welche die BSP-Sekretion zu begleiten scheint, Anhaltspunkte für die Ab klärung dieser Frage [27].…”
Section: Schicksal Von B S P Im Organismusunclassified